Key result
Serial CRP values in stable ischemic heart disease fluctuated considerably (within-patient variance 1.79 mg/L; 95% CI 1.60-2.00), causing 40.3% of patients to change risk category.
Observational (n=159)
Significant intra-individual fluctuations in CRP and IL-6 levels in stable ischemic heart disease patients suggest that single measurements may be unreliable for cardiovascular risk stratification.
Answers are grounded in this paper and cite their sources.
CRP variability may limit single-measurement risk stratification in stable IHD; leaves open whether serial assessments improve prediction.
Background C-reactive protein (CRP), a marker of inflammation, is increasingly measured to stratify coronary artery disease risk and guide clinical management. However, little is known about how inflammatory markers fluctuate over time in patients with stable ischemic heart disease. Methods We examined serial serum CRP values in 159 patients with histories spanning the clinical spectrum of ischemic heart disease. Two to 8 CRP measurements were made at intervals varying from 15 days to 6 years. Successive interleukin (IL)-6 values were examined in 1 subgroup. Blood samples were always taken when patients were clinically stable, in the absence of any potentially confounding inflammatory condition. Results C-reactive protein values in individual patients fluctuated considerably when examined in the following ranges: less than 1 mg/L, 1 to 3 mg/L, and greater than 3 mg/L, proposed to indicate low, average, and high risk. Sixty-four patients (40.3%) changed risk category between the first and the second measurement. Within-patient variances of CRP and IL-6 levels were 1.79 mg/L (95% confidence interval, 1.60-2.00) and 2.69 pg/mL (95% confidence interval, 2.29-3.18), respectively. The variability of CRP was consistent over different times and across clinical groups, and independent of body mass index, smoking status, medication, and clinical events. Conclusions Relatively important fluctuations in CRP levels in patients with stable ischemic heart disease may be problematic for risk stratification and treatment monitoring. A similar IL-6 variability suggests that these patients have a dynamic inflammatory status whose kinetics may modulate acute coronary risk.
No takes yet. Share an insight, caveat, or question.
Peter Bogaty (2005) conducted an observational in stable ischemic heart disease (n=159). Serial C-reactive protein (CRP) measurements was evaluated on Within-patient variance of CRP levels (1.79 mg/L, 95% CI 1.60-2.00). Serial CRP values in stable ischemic heart disease fluctuated considerably (within-patient variance 1.79 mg/L; 95% CI 1.60-2.00), causing 40.3% of patients to change risk category.
Synapse has enriched 10 related papers. Consider them for comparative context: